A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 33/24 (2006.01)
Patent
CA 2574450
This disclosure relates to the treatment of subjects at risk for chronic kidney disease (CKD), having stage one to five CKD, having hyperphosphataemia, susceptible to or suffering from soft tissue calcification associated with CKD, or susceptible to or suffering from hyperparathyroidism, by orally administering a pharmaceutical composition containing a therapeutically effective amount of lanthanum hydroxycarbonate.
L'invention concerne le traitement de sujets à risque de maladie rénale chronique (CKD), ces sujets présentant le stade un à cinq CKD et de l'hyperphosphatémie, étant susceptibles ou souffrant de calcification des tissus mous associée à la CKD, ou bien étant susceptibles ou souffrant d'hyperparathyroïdisme. Ce traitement consiste à administrer par voie orale une composition pharmaceutique contenant une quantité thérapeutiquement efficace d'hydroxycarbonate de lanthane.
Ferdinando Josephine Christine
Gilmour David
Robic
Shire Pharmaceuticals Inc.
LandOfFree
Method of treating hyperphosphataemia using lanthanum... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of treating hyperphosphataemia using lanthanum..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of treating hyperphosphataemia using lanthanum... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1730230